AC IMMUNE WKN: A2AR5F ISIN: CH0329023102 Kürzel: ACIU Forum: Aktien Thema: Hauptdiskussion

Diese Meilensteinzahlungen bringen uns hoffentlich in 3 bis 5 Jahren auch was😉

Was wichtig erscheint….. About AC Immune SA AC Immune SA is a clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen® and Morphomer®, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features ten therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.

An dieser Stelle möchte ich die Arbeit von Frau Dr. Andrea Pfeifer auch würdigen. Herzliche Gratulation aus Südamerika.

Es gibt da noch News, hatte dies heut im Postfach….. https://ir.acimmune.com/news-releases/news-release-details/ac-immune-ceo-andrea-pfeifer-receives-aenne-burda-award

Locker vom Hocker Kein Stress

....und wieso gibt's als Quelle finanzen.net an? Scroll drei Seiten zur Seite, da stehst doch 😏

Anhang seines Vermögens dieses abzuleiten, ist Unsinn.

Ob eine Investition spekulativ ist, das weiß nur der Investor selbst. Alles andere sind Mutmaßungen.